A. A. Fauser

2.4k total citations
44 papers, 1.6k citations indexed

About

A. A. Fauser is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, A. A. Fauser has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Hematology and 9 papers in Surgery. Recurrent topics in A. A. Fauser's work include Hematopoietic Stem Cell Transplantation (13 papers), Nausea and vomiting management (8 papers) and Neutropenia and Cancer Infections (6 papers). A. A. Fauser is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Nausea and vomiting management (8 papers) and Neutropenia and Cancer Infections (6 papers). A. A. Fauser collaborates with scholars based in Germany, France and United States. A. A. Fauser's co-authors include Nadežda Basara, M. Bischoff, L. Kraut, Klaus Schüle, Freerk T. Baumann, Wilhelm Bloch, Jürgen Finke, HJ Kolb, D Kirsten and S Günzelmann and has published in prestigious journals such as Clinical Infectious Diseases, European Journal of Cancer and Transplantation.

In The Last Decade

A. A. Fauser

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. A. Fauser Germany 21 890 463 300 250 226 44 1.6k
Ka Wah Chan United States 24 876 1.0× 413 0.9× 302 1.0× 178 0.7× 239 1.1× 67 1.8k
B Smedmyr Sweden 20 684 0.8× 280 0.6× 370 1.2× 79 0.3× 189 0.8× 38 1.2k
Michael Schleuning Germany 24 1.3k 1.4× 353 0.8× 304 1.0× 103 0.4× 467 2.1× 58 1.8k
Isabel Badell Spain 24 806 0.9× 311 0.7× 328 1.1× 131 0.5× 265 1.2× 108 1.6k
Michael L. Graham United States 15 781 0.9× 243 0.5× 144 0.5× 180 0.7× 281 1.2× 32 1.3k
M. Peetermans Belgium 23 1.4k 1.6× 384 0.8× 456 1.5× 83 0.3× 295 1.3× 72 2.2k
R Powles United Kingdom 19 645 0.7× 258 0.6× 310 1.0× 69 0.3× 228 1.0× 52 1.1k
JP Marie France 14 436 0.5× 736 1.6× 173 0.6× 89 0.4× 103 0.5× 26 1.4k
Felix Keil Austria 18 684 0.8× 299 0.6× 103 0.3× 92 0.4× 225 1.0× 81 1.1k
Manuel Moro Spain 15 394 0.4× 140 0.3× 135 0.5× 123 0.5× 196 0.9× 25 1.2k

Countries citing papers authored by A. A. Fauser

Since Specialization
Citations

This map shows the geographic impact of A. A. Fauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Fauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Fauser more than expected).

Fields of papers citing papers by A. A. Fauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Fauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Fauser. The network helps show where A. A. Fauser may publish in the future.

Co-authorship network of co-authors of A. A. Fauser

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Fauser. A scholar is included among the top collaborators of A. A. Fauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Fauser. A. A. Fauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baumann, Freerk T., L. Kraut, Klaus Schüle, Wilhelm Bloch, & A. A. Fauser. (2009). A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplantation. 45(2). 355–362. 128 indexed citations
3.
Kiehl, M. G., et al.. (2001). A prospective randomized trial comparing the efficacy and safety of piperacillin/tazobactam versus piperacillin/tazobactam plus netilmicin in the treatment of febrile neutropenia in allogeneic stem cell recipients. 41. 267. 2 indexed citations
4.
Basara, Nadežda, M. G. Kiehl, Eric J. Romer, et al.. (2001). Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience. Transplantation Proceedings. 33(3). 2121–2123. 38 indexed citations
5.
Basara, Nadežda, S Günzelmann, Wolfgang Willenbacher, A. A. Fauser, & M. G. Kiehl. (2001). New immunosuppressants in BMT/GVHD. Transplantation Proceedings. 33(3). 2220–2222. 8 indexed citations
6.
Schiedlmeier, Bernhard, Klaus Kühlcke, Stefan Früehauf, et al.. (2000). MDR1 Gene Expression in NOD/SCID Repopulating Cells after Retroviral Gene Transfer under Clinically Relevant Conditions. Molecular Therapy. 2(6). 609–618. 34 indexed citations
8.
Fauser, A. A., M. Fellhauer, Marc Hoffmann, et al.. (1999). Guidelines for anti-emetic therapy: acute emesis. European Journal of Cancer. 35(3). 361–370. 23 indexed citations
9.
Höffken, G., R. Pasold, Karl-Heinz Pflüger, et al.. (1999). An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. Journal of Antimicrobial Chemotherapy. 44(3). 367–376. 3 indexed citations
10.
Basara, Nadežda, Igor‐Wolfgang Blau, Michael Kiehl, et al.. (1998). Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation. Leukemia & lymphoma. 32(1-2). 189–193. 21 indexed citations
11.
Basara, Nadežda, Eric J. Romer, M. Bischoff, et al.. (1998). Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients. Bone Marrow Transplantation. 22(1). 61–65. 81 indexed citations
13.
Resche, I., J.F. Chatal, A Pecking, et al.. (1997). A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase. European Journal of Cancer. 33(10). 1583–1591. 179 indexed citations
14.
Fauser, A. A., Bernard Duclos, A. Chemaissani, et al.. (1996). Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Journal of Cancer. 32(9). 1523–1529. 28 indexed citations
15.
Conroy, Thierry, P Cappelaere, Michel Fabbro, et al.. (1994). Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin. American Journal of Clinical Oncology. 17(2). 97–102. 36 indexed citations
16.
Fauser, A. A., et al.. (1991). Antibiotische Behandlung der Sepsis mit Teicoplanin bei knochenmarktransplantierten Patienten. Oncology Research and Treatment. 14(3). 248–255. 2 indexed citations
18.
Volk, Benedikt, et al.. (1991). Expression of γδ T lymphocytes derived from human intestinal biopsies. Immunologic Research. 10(3-4). 310–312. 3 indexed citations
19.
Fauser, A. A., et al.. (1983). Reticulocytopenia in severe autoimmune hemolytic anemia (AIHA) of the warm antibody type. Annals of Hematology. 46(6). 321–327. 6 indexed citations
20.
Fauser, A. A., et al.. (1982). Suppressor T-cell clones derived from pluripotent stem cells (CFU-GEMM) of a patient with hodgkin's lymphoma. Annals of Hematology. 45(2). 97–102. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026